Device fundraising in the third quarter totaled $2.6 billion, a 24% decrease from Q2's $3.4 billion. Q3 M&A activity reached $5.6 billion, also a decline from the previous quarter. Q3 diagnostics financings totaled $900 million and M&As $532 million, both lower than Q2.
Exhibit 1
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?